{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:20:28Z","timestamp":1791267628250,"version":"4.1.0"},"reference-count":90,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2009,2,10]],"date-time":"2009-02-10T00:00:00Z","timestamp":1234224000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hematological Oncology"],"published-print":{"date-parts":[[2009,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Richter syndrome (RS) represents the clinico\u2010pathologic transformation of chronic lymphocytic leukaemia (CLL) to an aggressive lymphoma, most commonly diffuse large B\u2010cell lymphoma (DLBCL). The clinical definition of RS is heterogeneous, and encompasses at least two biologically different conditions: (i) CLL transformation to a clonally related DLBCL, that accounts for the majority of cases; (ii) development of a DLBCL unrelated to the CLL clone. In clonally related RS, the pathogenetic link between the CLL and the DLBCL phases is substantiated by the acquisition of novel molecular lesions at the time of clinico\u2010pathologic transformation. RS is not a rare event in the natural history of CLL, since the cumulative incidence of RS at 10 years exceeds 10%. Prompt recognition of RS is known to be clinically useful, and may be favoured by close monitoring of CLL patients harbouring clinical and\/or biological risk factors of RS development. Conventional risk factors that are independent predictors of RS development at the time of CLL diagnosis include: (i) expression of CD38; (ii) absence of del13q14 and (iii) lymph node size \u22653\u2009cm. Other risk factors of RS development include CD38 genotype and usage of specific immunoglobulin variable genes. The molecular pathogenesis of RS has been elucidated to a certain extent. Acquisition of<jats:italic>TP53<\/jats:italic>mutations and\/or 17p13 deletion is a frequent molecular event in RS, as it is in other types of transformation from indolent to aggressive B\u2010cell malignancies. Additional molecular alterations are being revealed by genome wide studies. Once that transformation has occurred, RS prognosis may be predicted by the RS score, based on performance status, LDH, platelet count, tumour size and number of prior therapies. Depending on patient's age and RS score, the therapeutic options for RS may range from conventional immunochemotherapy to allogeneic bone marrow transplantation. Copyright \u00a9 2009 John Wiley &amp; Sons, Ltd.<\/jats:p>","DOI":"10.1002\/hon.880","type":"journal-article","created":{"date-parts":[[2009,2,10]],"date-time":"2009-02-10T11:59:34Z","timestamp":1234267174000},"page":"1-10","source":"Crossref","is-referenced-by-count":99,"title":["Richter syndrome: molecular insights and clinical perspectives"],"prefix":"10.1002","volume":"27","author":[{"given":"Davide","family":"Rossi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Gaidano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,2,10]]},"reference":[{"key":"e_1_2_1_2_2","first-page":"285","article-title":"Generalized reticular cell sarcoma of lymph nodes associated with lymphatic leukaemia","volume":"4","author":"Richter MN","year":"1928","journal-title":"Am J Pathol"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-06-093906"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2008.07166.x"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20773"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2007.06801.x"},{"key":"e_1_2_1_7_2","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1182\/blood.V82.10.3141.3141","article-title":"Common clonal origin of chronic lymphocytic leukemia and high grade lymphoma of Richter's syndrome","volume":"82","author":"Cherepakhin V","year":"1993","journal-title":"Blood"},{"key":"e_1_2_1_8_2","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1182\/blood.V83.5.1363.1363","article-title":"Molecular genetic demonstration of the diverse evolution of Richter's syndrome (chronic lymphocytic leukemia and subsequent large cell lymphoma)","volume":"83","author":"Matolcsy A","year":"1994","journal-title":"Blood"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1827.2000.01094.x"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403249"},{"key":"e_1_2_1_11_2","first-page":"903","article-title":"Antigen receptors and somatic hypermutation in B\u2010cell chronic lymphocytic leukemia with Richter's transformation","volume":"91","author":"Smit LA","year":"2006","journal-title":"Haematologica"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e31804bdaf8"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11871"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.20712"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.09.3260"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.05.0187"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-08-106823"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.13103"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.9.2633"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.1.181"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-11-3890"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-06-094029"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-03-0989"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-01-013003"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-08-108605"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.25.15429"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002510050654"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-01-129726"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa050995"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.02.568"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.1.3"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2008.07398.x"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.15.4393"},{"issue":"1","key":"e_1_2_1_34_2","first-page":"162","article-title":"Short telomere length is an independent predictor of survival, progression, and Richter's syndrome transformation and recurrent infections: an analysis of 421 CLL patients including blinded validation on 230 cases","volume":"93","author":"Rossi D","year":"2008","journal-title":"Haematologica"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197802)41:2<422::AID-CNCR2820410207>3.0.CO;2-X"},{"key":"e_1_2_1_36_2","first-page":"609","article-title":"Localized gastric non\u2010Hodgkin's lymphoma of high\u2010grade malignancy in patients with pre\u2010existing chronic lymphocytic leukemia or immunocytoma","volume":"9","author":"Ott MM","year":"1995","journal-title":"Leukemia"},{"key":"e_1_2_1_37_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1999.02776.x"},{"key":"e_1_2_1_38_2","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3880333"},{"key":"e_1_2_1_39_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2008.07248.x"},{"key":"e_1_2_1_40_2","first-page":"1267","article-title":"Detection of Richter's transformation of chronic lymphocytic leukemia by PET\/CT","volume":"47","author":"Bruzzi JF","year":"2006","journal-title":"J Nucl Med"},{"key":"e_1_2_1_41_2","first-page":"207","article-title":"De novo CD5\u2010positive and Richter's syndrome\u2010associated diffuse large B cell lymphomas are genotypically distinct","volume":"147","author":"Matolcsy A","year":"1995","journal-title":"Am J Pathol"},{"key":"e_1_2_1_42_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-05-1545"},{"key":"e_1_2_1_43_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.88.12.5413"},{"key":"e_1_2_1_44_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V82.8.2289.2289"},{"key":"e_1_2_1_45_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0609.2003.00089.x"},{"key":"e_1_2_1_46_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403801"},{"key":"e_1_2_1_47_2","doi-asserted-by":"publisher","DOI":"10.1038\/nri2217"},{"key":"e_1_2_1_48_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2007.35"},{"key":"e_1_2_1_49_2","doi-asserted-by":"publisher","DOI":"10.1038\/35085588"},{"key":"e_1_2_1_50_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-11-3606"},{"key":"e_1_2_1_51_2","doi-asserted-by":"publisher","DOI":"10.1002\/path.1754"},{"key":"e_1_2_1_52_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404183"},{"key":"e_1_2_1_53_2","first-page":"1405","article-title":"Aberrant somatic hypermutation in transformation of follicular lymphoma and chronic lymphocytic leukemia to diffuse large B\u2010cell lymphoma","volume":"91","author":"Rossi D","year":"2006","journal-title":"Haematologica"},{"key":"e_1_2_1_54_2","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1200\/JCO.1984.2.10.1121","article-title":"Cytogenetic studies in 77 patients with chronic lymphocytic leukemia: correlations with clinical, immunologic, and phenotypic data","volume":"2","author":"Han T","year":"1984","journal-title":"J Clin Oncol"},{"key":"e_1_2_1_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-4608(94)90184-8"},{"key":"e_1_2_1_56_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/104.2.199"},{"key":"e_1_2_1_57_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(20000425)90:2<126::AID-CNCR8>3.0.CO;2-9"},{"key":"e_1_2_1_58_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-4608(99)00205-8"},{"key":"e_1_2_1_59_2","doi-asserted-by":"publisher","DOI":"10.1080\/10428190701882955"},{"key":"e_1_2_1_60_2","doi-asserted-by":"publisher","DOI":"10.1080\/1024533021000024058"},{"key":"e_1_2_1_61_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.05.012"},{"key":"e_1_2_1_62_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)64256-3"},{"key":"e_1_2_1_63_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0609.2002.01599.x"},{"key":"e_1_2_1_64_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2004.09.008"},{"key":"e_1_2_1_65_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19810915)48:6<1302::AID-CNCR2820480609>3.0.CO;2-Q"},{"key":"e_1_2_1_66_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1993.11.10.1985"},{"key":"e_1_2_1_67_2","doi-asserted-by":"publisher","DOI":"10.3109\/10428190109064589"},{"key":"e_1_2_1_68_2","doi-asserted-by":"publisher","DOI":"10.1080\/10428190290016872"},{"key":"e_1_2_1_69_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11238"},{"key":"e_1_2_1_70_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.10240"},{"key":"e_1_2_1_71_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011795"},{"key":"e_1_2_1_72_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.11.8513"},{"key":"e_1_2_1_73_2","first-page":"522","article-title":"Cytosine arabinoside (ara\u2010C) and cis\u2010dichlorodiammineplatinum II (cisplatin) alone and in combination: effects on acute myeloblastic leukemia blast cells in culture and in vivo","volume":"5","author":"Wang YF","year":"1991","journal-title":"Leukemia"},{"key":"e_1_2_1_74_2","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/S0026-895X(25)08597-9","article-title":"Arabinosyl\u20102\u2010fluoroadenine augments cisplatin cytotoxicity and inhibits cisplatin\u2010DNA cross\u2010link repair","volume":"47","author":"Yang LY","year":"1995","journal-title":"Mol Pharmacol"},{"key":"e_1_2_1_75_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1012501305214"},{"key":"e_1_2_1_76_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2001.03181.x"},{"key":"e_1_2_1_77_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-07-1952"},{"key":"e_1_2_1_78_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20252"},{"key":"e_1_2_1_79_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.09.027"},{"key":"e_1_2_1_80_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11871"},{"key":"e_1_2_1_81_2","doi-asserted-by":"publisher","DOI":"10.1080\/10428190310001615675"},{"key":"e_1_2_1_82_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403354"},{"key":"e_1_2_1_83_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.04.6037"},{"key":"e_1_2_1_84_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.23144"},{"key":"e_1_2_1_85_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.23271"},{"key":"e_1_2_1_86_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdm560"},{"key":"e_1_2_1_87_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2000.02295.x"},{"key":"e_1_2_1_88_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.05.0401"},{"key":"e_1_2_1_89_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-05-020735"},{"key":"e_1_2_1_90_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-09-111781"},{"key":"e_1_2_1_91_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-12-130120"}],"container-title":["Hematological Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhon.880","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hon.880","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T15:26:14Z","timestamp":1738941974000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/hon.880"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2,10]]},"references-count":90,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["10.1002\/hon.880"],"URL":"https:\/\/doi.org\/10.1002\/hon.880","archive":["Portico"],"relation":{},"ISSN":["0278-0232","1099-1069"],"issn-type":[{"value":"0278-0232","type":"print"},{"value":"1099-1069","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2,10]]}}}